메뉴 건너뛰기




Volumn 39, Issue 4, 2010, Pages 777-790

Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: Application to diagnosis, monitoring disease, and as prognostic indicators

Author keywords

Circulating biomarkers; Disease monitoring; Neuroendocrine tumors; Prognostic indicators

Indexed keywords

C PEPTIDE; CHROMOGRANIN A; CHROMOGRANIN B; GASTRIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; PANCREASTATIN; PEPTIDE DERIVATIVE; PROINSULIN; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE; SULFONYLUREA DERIVATIVE; TACHYKININ DERIVATIVE; TUMOR MARKER;

EID: 78649391212     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.09.001     Document Type: Review
Times cited : (34)

References (28)
  • 1
    • 0346457248 scopus 로고    scopus 로고
    • The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut
    • Ardill J.E., Eriksson B. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut. Endocr Relat Cancer 2003, 10(4):459-462.
    • (2003) Endocr Relat Cancer , vol.10 , Issue.4 , pp. 459-462
    • Ardill, J.E.1    Eriksson, B.2
  • 2
    • 0031393576 scopus 로고    scopus 로고
    • Biochemical diagnosis of neuroendocrine GEP tumors
    • Öberg K. Biochemical diagnosis of neuroendocrine GEP tumors. Yale J Biol Med 1997, 70:501-508.
    • (1997) Yale J Biol Med , vol.70 , pp. 501-508
    • Öberg, K.1
  • 3
  • 4
    • 0025992282 scopus 로고
    • The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera
    • Curry W.J., Johnston C.F., Hutton C.J., et al. The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry 1991, 96:531-538.
    • (1991) Histochemistry , vol.96 , pp. 531-538
    • Curry, W.J.1    Johnston, C.F.2    Hutton, C.J.3
  • 5
    • 0025736908 scopus 로고
    • Pancreastatin-like immunoreactivity in human carcinoid disease
    • McGrath-Lindin S.J., Johnston C.F., O'Connor D.T., et al. Pancreastatin-like immunoreactivity in human carcinoid disease. Regul Pept 1991, 33:55-70.
    • (1991) Regul Pept , vol.33 , pp. 55-70
    • McGrath-Lindin, S.J.1    Johnston, C.F.2    O'Connor, D.T.3
  • 6
    • 78649348676 scopus 로고
    • Measurement of chromogranin A, chromogranin B (secretogranin 1) chromogranin C (secretogranin 11) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours
    • Stridsberg M., Öberg K., Li Q., et al. Measurement of chromogranin A, chromogranin B (secretogranin 1) chromogranin C (secretogranin 11) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995, 426:361-367.
    • (1995) J Endocrinol , vol.426 , pp. 361-367
    • Stridsberg, M.1    Öberg, K.2    Li, Q.3
  • 7
    • 78649377966 scopus 로고    scopus 로고
    • Regional laboratory audit to evaluate specificity and sensitivity of chromogranin A and peptide markers in neuroendocrine tumours [abstract]
    • PO12
    • Armstrong L., Ardill J.E. Regional laboratory audit to evaluate specificity and sensitivity of chromogranin A and peptide markers in neuroendocrine tumours [abstract]. Regul Pept 2010, 164:11. PO12.
    • (2010) Regul Pept , vol.164 , pp. 11
    • Armstrong, L.1    Ardill, J.E.2
  • 8
    • 55949102682 scopus 로고    scopus 로고
    • A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours
    • Stronge R.L., Turner G.B., Johnston B.T., et al. A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. Ann Clin Biochem 2008, 45:560-566.
    • (2008) Ann Clin Biochem , vol.45 , pp. 560-566
    • Stronge, R.L.1    Turner, G.B.2    Johnston, B.T.3
  • 9
    • 77954099329 scopus 로고    scopus 로고
    • Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior
    • O'Dorisio T.M., Krutzik S.R., Woltering E.A., et al. Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior. Pancreas 2010, 39(5):611-616.
    • (2010) Pancreas , vol.39 , Issue.5 , pp. 611-616
    • O'Dorisio, T.M.1    Krutzik, S.R.2    Woltering, E.A.3
  • 10
    • 33846841131 scopus 로고    scopus 로고
    • Measurement of Chromogranin B can serve as a complement to chromogranin A
    • Stridsberg M., Eriksson B., Fellström B., et al. Measurement of Chromogranin B can serve as a complement to chromogranin A. Regul Pept 2007, 139:80-83.
    • (2007) Regul Pept , vol.139 , pp. 80-83
    • Stridsberg, M.1    Eriksson, B.2    Fellström, B.3
  • 11
    • 0023190024 scopus 로고
    • Carcinoids associated with multiple endocrine neoplasia syndromes
    • Duh Q., Hybarger C.P., Geist R., et al. Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 1987, 154:142-148.
    • (1987) Am J Surg , vol.154 , pp. 142-148
    • Duh, Q.1    Hybarger, C.P.2    Geist, R.3
  • 13
    • 0031774624 scopus 로고    scopus 로고
    • Gastrinomas and the change in their presentation and management in Northern Ireland, UK, from 1970 to 1996
    • Larkin C.J., Ardill J.E., Johnston C.F., et al. Gastrinomas and the change in their presentation and management in Northern Ireland, UK, from 1970 to 1996. Eur J Gastroenterol Hepatol 1998, 10(11):947-952.
    • (1998) Eur J Gastroenterol Hepatol , vol.10 , Issue.11 , pp. 947-952
    • Larkin, C.J.1    Ardill, J.E.2    Johnston, C.F.3
  • 14
    • 33644679953 scopus 로고    scopus 로고
    • Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists
    • Dhillo W.S., Jayasena C.N., Lewis C.J., et al. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Ann Clin Biochem 2006, 43:153-155.
    • (2006) Ann Clin Biochem , vol.43 , pp. 153-155
    • Dhillo, W.S.1    Jayasena, C.N.2    Lewis, C.J.3
  • 15
    • 0024452031 scopus 로고
    • Secretin and calcium provocative tests in the Zollinger-Ellison syndrome A prospective study
    • Frucht H., Howard J.M., Slaff J.I., et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome A prospective study. Ann Intern Med 1989, 111(9):713-722.
    • (1989) Ann Intern Med , vol.111 , Issue.9 , pp. 713-722
    • Frucht, H.1    Howard, J.M.2    Slaff, J.I.3
  • 16
    • 0030012124 scopus 로고    scopus 로고
    • Role of prohormone convertase in the tissue-specific processing of proglucagon
    • Dhanvantari S., Seidah N.G., Brubaker P.L. Role of prohormone convertase in the tissue-specific processing of proglucagon. Mol Endocrinol 1996, 10:342-355.
    • (1996) Mol Endocrinol , vol.10 , pp. 342-355
    • Dhanvantari, S.1    Seidah, N.G.2    Brubaker, P.L.3
  • 17
    • 0033993906 scopus 로고    scopus 로고
    • Structure, measurement, and secretion of human glucagon-like peptide-2
    • Hartmann B., Johnsen A.H., Ørskov C., et al. Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides 2000, 21(1):73-80.
    • (2000) Peptides , vol.21 , Issue.1 , pp. 73-80
    • Hartmann, B.1    Johnsen, A.H.2    Ørskov, C.3
  • 18
    • 55949116969 scopus 로고    scopus 로고
    • A significant number of spontaneous gastrinomas secrete multiple peptides worsening prognosis
    • [Abstract]
    • Ardill J.E., Fillmore D., Johnston C.F., et al. A significant number of spontaneous gastrinomas secrete multiple peptides worsening prognosis. Digestion 1999, 60:613. [Abstract].
    • (1999) Digestion , vol.60 , pp. 613
    • Ardill, J.E.1    Fillmore, D.2    Johnston, C.F.3
  • 19
    • 33750296895 scopus 로고    scopus 로고
    • Circulating markers of prognosis and response to treatment with midgut carcinoid tumours
    • Turner G.B., Johnston B.T., McCance D.R., et al. Circulating markers of prognosis and response to treatment with midgut carcinoid tumours. Gut 2006, 55:1586-1591.
    • (2006) Gut , vol.55 , pp. 1586-1591
    • Turner, G.B.1    Johnston, B.T.2    McCance, D.R.3
  • 20
    • 55949130646 scopus 로고    scopus 로고
    • Circulating markers for endocrine tumours of the gastroenteropancreatic tract
    • [Review]
    • Ardill J.E. Circulating markers for endocrine tumours of the gastroenteropancreatic tract. Ann Clin Biochem 2008, 45(6):539-559. [Review].
    • (2008) Ann Clin Biochem , vol.45 , Issue.6 , pp. 539-559
    • Ardill, J.E.1
  • 22
    • 0031883845 scopus 로고    scopus 로고
    • The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment
    • Shi W., Buchanan K.D., Johnston C.F., et al. The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment. Clin Endocrinol (Oxf) 1998, 48(3):303-309.
    • (1998) Clin Endocrinol (Oxf) , vol.48 , Issue.3 , pp. 303-309
    • Shi, W.1    Buchanan, K.D.2    Johnston, C.F.3
  • 23
    • 72749114281 scopus 로고    scopus 로고
    • Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
    • Ahmed A., Turner G., King B., et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 2009, 16(3):885-894.
    • (2009) Endocr Relat Cancer , vol.16 , Issue.3 , pp. 885-894
    • Ahmed, A.1    Turner, G.2    King, B.3
  • 24
    • 0033498897 scopus 로고    scopus 로고
    • Prognosis and survival in patients with gastrointestinal tract carcinoid tumors
    • [discussion: 822-3]
    • Shebani K.O., Souba W.W., Finkelstein D.M., et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999, 229(6):815-821. [discussion: 822-3].
    • (1999) Ann Surg , vol.229 , Issue.6 , pp. 815-821
    • Shebani, K.O.1    Souba, W.W.2    Finkelstein, D.M.3
  • 25
    • 0030937908 scopus 로고    scopus 로고
    • Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases
    • Burke A.P., Thomas R.M., Elsayed A.M., et al. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997, 79(6):1086-1093.
    • (1997) Cancer , vol.79 , Issue.6 , pp. 1086-1093
    • Burke, A.P.1    Thomas, R.M.2    Elsayed, A.M.3
  • 26
    • 85047700307 scopus 로고
    • A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system
    • Chaudhry A., Öberg K., Wilander E. A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system. Tumour Biol 1992, 13(1-2):27-35.
    • (1992) Tumour Biol , vol.13 , Issue.1-2 , pp. 27-35
    • Chaudhry, A.1    Öberg, K.2    Wilander, E.3
  • 27
    • 0030807282 scopus 로고    scopus 로고
    • Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center
    • Janson E.T., Holmberg L., Stridsberg M., et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997, 8(7):685-690.
    • (1997) Ann Oncol , vol.8 , Issue.7 , pp. 685-690
    • Janson, E.T.1    Holmberg, L.2    Stridsberg, M.3
  • 28
    • 78649349539 scopus 로고    scopus 로고
    • Neurokinin A is a sensitive marker and excellent prognostic indicator for serotonin secreting tumours of the ileum and colon
    • OC04
    • Ardill J.E., Armstrong L., McCance D.R., et al. Neurokinin A is a sensitive marker and excellent prognostic indicator for serotonin secreting tumours of the ileum and colon. Regul Pept 2010, 164:7. OC04.
    • (2010) Regul Pept , vol.164 , pp. 7
    • Ardill, J.E.1    Armstrong, L.2    McCance, D.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.